| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
51 |
| Employees |
325 |
| Revenues (TTM) (Millions $) |
431 |
| Net Income (TTM) (Millions $) |
-6 |
| Cash Flow (TTM) (Millions $) |
114 |
| Capital Exp. (TTM) (Millions $) |
9 |
Business Description
Axonics Inc. is a medical technology company that develops and commercializes sacral neuromodulation systems for the treatment of urinary and bowel dysfunction. They are headquartered in Irvine, California, and operate globally.
Axonics' lead product, the Axonics Sacral Neuromodulation System, is a rechargeable implantable device that provides nerve stimulation to modulate the activity of the bladder and pelvic floor muscles. The device is implanted in the upper buttock area and connected to a lead that is positioned next to the sacral nerves. It is powered by a small, surgically-implanted battery that is designed to last up to 15 years. The device is controlled by a small, hand-held wireless programmer that allows patients to adjust the stimulation intensity and the frequency of the stimulation.
The Axonics system is designed to treat a range of clinical conditions, including overactive bladder, urinary retention, fecal incontinence, and chronic constipation. The system has been clinically proven to be safe and effective, with high success rates and low complication rates. Axonics received FDA approval in September 2019 for its sacral neuromodulation system for the treatment of patients with urinary dysfunction.
Axonics' mission is to provide patients suffering from urinary and bowel dysfunction with an alternative to traditional therapies such as medications and invasive surgeries. They focus on developing innovative technologies that are less invasive, more effective, and longer lasting than current treatments.
Axonics is committed to providing exceptional customer service and support to patients, healthcare providers, and their distribution partners. They have an experienced team of professionals dedicated to patient care and product development and are continuing to expand their global reach through regulatory approvals and partnerships.
Company Address: 26 Technology Drive Irvine, 92618 CA
Company Phone Number: 396-6322 Stock Exchange / Ticker: NASDAQ AXNX
|
%
1.92%